NTI-ADDAE, Kwame W.,PRASAD, Leena Kumari,STORZ, Thomas
申请号：
AU2019231724
公开号：
AU2019231724A1
申请日:
2019.03.07
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present disclosure relates to crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[l,2-a]pyrazine, which are useful as a stimulator of soluble guanylate cyclase (sGC). The present disclosure also provides pharmaceutically acceptable compositions comprising the crystalline forms and methods of using said compositions in the treatment of various disorders.
